AIM: To determine the potential for drug interactions involving cytochrome P450 (CYP) in patients receiving palliative day care. METHODS: Drugs used by patients attending four specialist palliative day care centres were reviewed to identify combinations that could result in a pharmacokinetic interaction via any of the five main human forms of CYP. RESULTS: Of 160 patients, 145 (91%) were prescribed at least one drug that was a substrate, inhibitor or inducer of one of the five main CYP isoforms. Twenty-four drug combinations, involving 34 patients, could have given rise to a clinically important interaction. CONCLUSIONS: Prescribers should be aware that in this group of patients, one in five are at risk of a clinically important CYP-mediated drug interaction.
AIM: To determine the potential for drug interactions involving cytochrome P450 (CYP) in patients receiving palliative day care. METHODS: Drugs used by patients attending four specialist palliative day care centres were reviewed to identify combinations that could result in a pharmacokinetic interaction via any of the five main human forms of CYP. RESULTS: Of 160 patients, 145 (91%) were prescribed at least one drug that was a substrate, inhibitor or inducer of one of the five main CYP isoforms. Twenty-four drug combinations, involving 34 patients, could have given rise to a clinically important interaction. CONCLUSIONS: Prescribers should be aware that in this group of patients, one in five are at risk of a clinically important CYP-mediated drug interaction.
Authors: J S McCune; R L Hawke; E L LeCluyse; H H Gillenwater; G Hamilton; J Ritchie; C Lindley Journal: Clin Pharmacol Ther Date: 2000-10 Impact factor: 6.875
Authors: Dany Anglicheau; Martin Flamant; Marie Hélène Schlageter; Frank Martinez; Bruno Cassinat; Philippe Beaune; Christophe Legendre; Eric Thervet Journal: Nephrol Dial Transplant Date: 2003-11 Impact factor: 5.992
Authors: Michael J McNeil; Arif H Kamal; Jean S Kutner; Christine S Ritchie; Amy P Abernethy Journal: J Pain Symptom Manage Date: 2015-09-30 Impact factor: 3.612
Authors: María Espinosa-Bosch; Bernardo Santos-Ramos; María Victoria Gil-Navarro; María Dolores Santos-Rubio; Roberto Marín-Gil; Paloma Villacorta-Linaza Journal: Int J Clin Pharm Date: 2012-09-11